ストックスクリーナーアプリを入手
37.46
1.63%
0.60
Crinetics Pharmaceuticals Inc (CRNX) 最新ニュース
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Crinetics Pharmaceuticals to Participate in Two Upcoming March Investor Conferences - GlobeNewswire
Objective long/short (CRNX) Report - Stock Traders Daily
Crinetics Pharmaceuticals (CRNX) Expected to Announce Earnings on Wednesday - MarketBeat
TD Cowen initiates Crinetics stock with Buy rating, sees high potential - MSN
Crinetics Pharmaceuticals (NASDAQ:CRNX) Sets New 12-Month LowWhat's Next? - MarketBeat
Crinetics Pharmaceuticals (NASDAQ:CRNX) Coverage Initiated at TD Cowen - MarketBeat
abrdn plc Acquires 7,922 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - MarketBeat
Crinetics Pharmaceuticals (NASDAQ:CRNX) Research Coverage Started at TD Cowen - Defense World
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World
Janney Montgomery Scott LLC Purchases 600 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World
TD Cowen gives a Buy recommendation for Crinetics Pharmaceuticals Inc (CRNX) - Knox Daily
CRNX stock touches 52-week low at $35.47 amid market shifts - MSN
Leerink Partnrs Issues Negative Estimate for CRNX Earnings - MarketBeat
Crinetics Pharmaceuticals (NASDAQ:CRNX) Reaches New 1-Year Low – Time to Sell? - Defense World
Stock Performance Spotlight: Crinetics Pharmaceuticals Inc (CRNX) Ends the Day at 36.53, Down by -1.22 - The Dwinnex
Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Crinetics (CRNX) Awards $3.8M in Equity Incentives to Expand TeamKey Details - StockTitan
(CRNX) Technical Pivots with Risk Controls - Stock Traders Daily
Dana Pizzuti Sells 5,000 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Stock - MarketBeat
Calamos Advisors LLC Sells 27,156 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - MarketBeat
Crinetics Pharmaceuticals (NASDAQ:CRNX) Coverage Initiated at Wolfe Research - MarketBeat
What is Leerink Partnrs’ Estimate for CRNX Q3 Earnings? - Defense World
Jennison Associates LLC Has $138.48 Million Position in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - MarketBeat
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - The Manila Times
Crinetics Q4 Earnings Date Confirmed: Key Financial Updates Expected Feb 27 - StockTitan
Crinetics Pharmaceuticals Inc (CRNX)’s Market Momentum: Closing Strong at 39.30, Down -2.72 - The Dwinnex
An analyst sees good growth prospects for Crinetics Pharmaceuticals Inc (CRNX) - SETE News
Wolfe Research Begins Coverage on Crinetics Pharmaceuticals (NASDAQ:CRNX) - Defense World
Crinetics Pharmaceuticals exec sells shares worth $195,350 By Investing.com - Investing.com Nigeria
Crinetics Pharmaceuticals exec sells shares worth $195,350 - MSN
Crinetics Pharmaceuticals, Inc. (CRNX): One of January’s Biggest Losers - Insider Monkey
Keeping an Eye on Crinetics Pharmaceuticals Inc (CRNX) After Insider Trading Activity - Knox Daily
Wolfe Research Initiates Coverage of Crinetics Pharmaceuticals (CRNX) with Peer Perform Recommendation - MSN
KBC Group NV Grows Stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):